基本信息
views: 442
Career Trajectory
Bio
“长江学者”特聘教授、国家“国家高层次人才”,国家重大科学研究计划项目(973)首席科学家。学术兼职包括泛亚多发性硬化治疗和研究委员会(PACTRIMS)委员,中华医学会神经病学分会委员会常务委员,天津市医学会神经病学分会主任委员。获得首届“中国卒中创新研究奖”、第三届“中国卒中奖”、“中国杰出神经内科医师”称号。获得美国发明专利1项。
施福东长期致力于研究天然免疫在神经疾病中的作用,并探索新的免疫治疗策略。近年发现了脑内炎症和免疫反应的特异性,完善了神经免疫疾病的实验室辅助诊断,寻找出适合我国国情的视神经脊髓炎的治疗方案,对脑血管病的免疫机制和免疫干预进行了开创性的探索。
Research Interests
Papers共 372 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jiejie Li,Xia Meng,Fu-Dong Shi, Jing,Hong-Qiu Gu,Aoming Jin,Yong Jiang,Hao Li,S Claiborne Johnston,Graeme J Hankey,J Donald Easton,Liguo Chang, Penglai Shi,Lihua Wang,Xianbo Zhuang, Haitao Li,Yingzhuo Zang, Jianling Zhang, Zengqiang Sun,Dongqi Liu, Ying Li,Hongqin Yang,Jinguo Zhao,Weiran Yu,Anxin Wang,Yuesong Pan,Jinxi Lin,Xuewei Xie,Wei-Na Jin,Shuya Li,Siying Niu,Yilong Wang,Xingquan Zhao,Zixiao Li,Liping Liu,Huaguang Zheng,Yongjun Wang, CHANCE-3 Investigators
BMJpp.e079061-e079061, (2024)
Ai Guo,Zhe Zhang,Ge-Hong Dong,Lei Su,Chenyang Gao, Mengting Zhang, Xiaoyu Shi,Huabing Wang,Xinghu Zhang,De-Hong Lu,Ying Fu, Jing,Fu-Dong Shi,De-Cai Tian
Aging and diseaseno. 2 (2024): 824-830
Shihe Jiang, Xiuchen Guan, Meng Shi, Ying Zhang,Xindi Li,Yingying Su,Hao Wang,Jian Zhou,Fu-Dong Shi,Songling Wang,Wei-Na Jin
Brain & Heartno. 0 (2024)
The Lancet Neurologyno. 6 (2024): 549-550
SCIENCE TRANSLATIONAL MEDICINEno. 736 (2024)
Hui-Ning Li, Xiao-Na Xu, Ying-Hui Qin, Rui Liu, Wen-Yue Guo, Xiao-Yu Huang,Mo-Li Fan,Lin-Jie Zhang,Yuan Qi,Chao Zhang,Li Yang,Fu-Dong Shi, Chun-Sheng Yang
FRONTIERS IN PUBLIC HEALTH (2024)
Load More
Author Statistics
#Papers: 372
#Citation: 16029
H-Index: 72
G-Index: 114
Sociability: 7
Diversity: 0
Activity: 3
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn